𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression

✍ Scribed by Mick D. Edmonds; Douglas R. Hurst; Kedar S. Vaidya; Lewis J. Stafford; Dongquan Chen; Danny R. Welch


Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
159 KB
Volume
125
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis of multiple tumor types without blocking tumorigenesis. BRMS1 forms complexes with SIN3, histone deacetylases and selected transcription factors that modify metastasis‐associated gene expression (e.g., EGFR, OPN, PI4P5K1A, PLAU). microRNA (miRNA) are a recently discovered class of regulatory, noncoding RNA, some of which are involved in neoplastic progression. Based on these data, we hypothesized that BRMS1 may also exert some of its antimetastatic effects by regulating miRNA expression. MicroRNA arrays were done comparing small RNAs that were purified from metastatic MDA‐MB‐231 and MDA‐MB‐435 and their nonmetastatic BRMS1‐transfected counterparts. miRNA expression changed by BRMS1 were validated using SYBR Green RT‐PCR. BRMS1 decreased metastasis‐promoting (miR‐10b, ‐373 and ‐520c) miRNA, with corresponding reduction of their downstream targets (e.g., RhoC which is downstream of miR‐10b). Concurrently, BRMS1 increased expression of metastasis suppressing miRNA (miR‐146a, ‐146b and ‐335). Collectively, these data show that BRMS1 coordinately regulates expression of multiple metastasis‐associated miRNA and suggests that recruitment of BRMS1‐containing SIN3:HDAC complexes to, as yet undefined, miRNA promoters might be involved in the regulation of cancer metastasis. © 2009 UICC


📜 SIMILAR VOLUMES


BRCA1 expression levels predict distant
✍ Liam T. Seery; Janice M. Knowlden; Julia M.W. Gee; John F.R. Robertson; Francis 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 2 views

The role of BRCA1 in progression of sporadic breast cancers has to date been equivocal, although preliminary studies on small numbers of samples have suggested an association between expression levels of this gene and acquisition of an invasive phenotype. We have further reasoned that loss of oestro

Identification and characterization of t
✍ Rajeev S. Samant; Michael T. Debies; Lalita A. Shevde; Michael F. Verderame; Dan 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 151 KB 👁 1 views

## Abstract We have cloned a novel metastasis‐suppressor gene __(BRMS1)__ by differential display, comparing metastatic human breast carcinoma cell line MDA‐MB‐435 to its metastasis‐suppressed human chromosome 11 microcell hybrid. Screening of a murine cDNA library led to the identification of a 1.

Relationship between expression of the K
✍ Ow, Kim; Delprado, Warick; Fisher, Richard; Barrett, Julie; Yu, Yan; Jackson, Pa 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB 👁 2 views

Expression of a newly described inhibitor of tumour metastasis, KAI1, was examined in bladder cancer progression and compared with the expression of p53 and pRb, which are markers of advanced disease. KAI1 mRNA (by in situ hybridization) and protein levels (by immunohistochemistry) were examined in

Expression of the prostate cancer metast
✍ Bouras, Toula; Frauman, Albert G. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB 👁 2 views

The KAI1 gene, isolated from human chromosome 11p11.2, has been implicated as a prostate cancer metastasis suppressor gene. Recent studies have demonstrated that the expression of KAI1 protein is reduced in metastases of human prostate cancers and is inversely correlated with tumour grade. The objec

Down-regulation of the transcriptional m
✍ Padmaja Gade; Ashish K. Singh; Sanjit K. Roy; Sekhar P. Reddy; Dhananjaya V. Kal 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 396 KB

## Abstract DAPK1, a ca^+2^/calmodulin regulated serine/threonine kinase, is a major tumor suppressor, whose expression is lost in multiple tumor types. However, the mechanisms contributing to it are unclear. We have recently shown that CCAAT/Enhancer binding protein‐β (C/EBP‐β) is required for the